Journey Medical Corporation
NASDAQ: DERM0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Claude Maraoui
- Employees
- 41
- Headquarters
- Scottsdale, United States
- IPO year
- 2021
- Market cap
- $188.5M
- Website
- https://journeymedicalcorp.com
Loading DERM…
Loading profile data…Frequently asked questions about DERM
What does Journey Medical Corporation (DERM) do?
Journey Medical Corporation, a pharmaceutical firm established in Scottsdale, Arizona in 2014 (and previously known as Coronado Dermatology, Inc.), is dedicated to the development and market introduction of treatments for skin conditions across the United States. Their product line encompasses key dermatological therapies such as Qbrexza, a medi...
Where does DERM trade?
Journey Medical Corporation (DERM) trades on the NASDAQ Capital Market.
What sector is DERM in?
Journey Medical Corporation (DERM) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Journey Medical Corporation?
Claude Maraoui is the chief executive officer of Journey Medical Corporation (DERM).
Where is Journey Medical Corporation headquartered?
Journey Medical Corporation is headquartered in United States.
Does DERM pay a dividend?
Journey Medical Corporation (DERM) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did DERM go public?
Journey Medical Corporation (DERM) completed its initial public offering in 2021.